NCT05591703View on ClinicalTrials.gov

Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

November 21, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Opioid Use DisorderRelapse
Interventions
BEHAVIORAL

Clinical Outcomes and Questionnaires

Clinical patient-reported outcomes will be administered remotely at specified timepoints. No treatment or intervention will be administered in this protocol.

Trial Locations (3)

55012

Hazelden Betty Ford Foundation, Center City

55441

Hazelden Betty Ford Foundation, Plymouth

92270

Betty Ford Foundation, Rancho Mirage

All Listed Sponsors
collaborator

Hazelden Betty Ford Foundation

UNKNOWN

lead

Spark Biomedical, Inc.

INDUSTRY